...
首页> 外文期刊>International immunology. >EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC.
【24h】

EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC.

机译:EBI1配体趋化因子(ELC)吸引了广泛的淋巴细胞:活化的T细胞强烈上调CCR7,并有效地向ELC迁移。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

EBI1-ligand chemokine (ELC) is a CC chemokine constitutively expressed in various lymphoid tissues and a high-affinity functional ligand for EBI1/CCR7, a seven transmembrane G-protein-coupled receptor originally identified as an Epstein-Barr virus (EBV)-inducible gene. Here we examined chemotactic activity of ELC on peripheral blood leukocytes. ELC attracted both CD4+ and CD8+ T cells, particularly efficiently after activation with IL-2 or with phytohemagglutinin (PHA) plus IL-2, as well as CD19+ B cells, but not CD16+ NK cells, CD14+ monocytes or neutrophils. Among CD3+ T cells, ELC attracted both CD45RO- naive and CD45RO+ memory subsets. ELC also induced vigorous calcium mobilization in T cells stimulated with IL-2 with an ED50 of 3 nM. ELC fused with the secreted form of alkaline phosphatase (ELC-SEAP) specifically bound to lymphocytes and this binding was blocked only by ELC among 10 CC chemokines so far tested. Notably, lymphocytes stimulated with IL-2 or T cells expanded by PHA plus IL-2 showed much higher levels of binding than fresh lymphocytes. Consistently, CCR7 mRNA was detected in CD4+ and CD8+ T cells as well as B cells, but not in NK cells, monocytes or neutrophils, and was dramatically increased in T cells upon treatment with IL-2 or with PHA plus IL-2. Like ELC mRNA, CCR7 mRNA was expressed in various lymphoid tissues. By in situ hybridization, ELC and CCR7 mRNA were detected in the parafollicular and inner cortical regions of a lymph node, and in the parafollicular regions of an appendix. Collectively, ELC and CCR7 may be involved in the trafficking of a broad spectrum of lymphocytes, especially activated T cells, into and within various lymphoid tissues.
机译:EBI1-配体趋化因子(ELC)是在多种淋巴组织中组成型表达的CC趋化因子,是EBI1 / CCR7的高亲和力功能配体,EBI1 / CCR7是七种跨膜G蛋白偶联受体,最初被确定为爱泼斯坦-巴尔病毒(EBV)-诱导基因。在这里,我们检查了ELC对外周血白细胞的趋化活性。 ELC吸引了CD4 +和CD8 + T细胞,特别是在用IL-2或植物血凝素(PHA)加IL-2激活后,以及在CD19 + B细胞,但未在CD16 + NK细胞,CD14 +单核细胞或嗜中性白细胞活化后,特别有效。在CD3 + T细胞中,ELC吸引了CD45RO-naive和CD45RO +记忆子集。 ELC还在ED50为3 nM的IL-2刺激的T细胞中诱导了强烈的钙动员。与分泌形式的碱性磷酸酶(ELC-SEAP)融合的ELC与淋巴细胞特异性结合,到目前为止,在10种CC趋化因子中,这种结合仅被ELC阻断。值得注意的是,用PHA加IL-2扩增的IL-2或T细胞刺激的淋巴细胞的结合水平要比新鲜淋巴细胞高得多。一致地,在CD4 +和CD8 + T细胞以及B细胞中检测到CCR7 mRNA,但在NK细胞,单核细胞或中性粒细胞中未检测到CCR7 mRNA,并且在用IL-2或PHA加IL-2治疗后T细胞中CCR7 mRNA显着增加。像ELC mRNA一样,CCR7 mRNA在各种淋巴组织中表达。通过原位杂交,在淋巴结的滤泡旁和皮层内区域以及阑尾的滤泡旁区域中检测到ELC和CCR7 mRNA。总的来说,ELC和CCR7可能参与多种淋巴细胞,特别是活化的T细胞进入和进入各种淋巴组织的运输。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号